Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,390,020
-
Total 13F shares
-
3,279,360
-
Share change
-
+1,572,540
-
Total reported value
-
$1,729,000
-
Price per share
-
$0.53
-
Number of holders
-
20
-
Value change
-
+$775,233
-
Number of buys
-
11
-
Number of sells
-
9
Institutional Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) as of Q3 2022
As of 30 Sep 2022,
Arcadia Biosciences, Inc. - Common Stock (RKDA) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,279,360 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, TWO SIGMA SECURITIES, LLC, LPL Financial LLC, HighTower Advisors, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
20
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.